Beeld op de omslag

Worldwide remerging of SARS CoV-2 (Severe acute respiratory syndrome coronavirus 2) linked with COVID-19: current status and prospects

<p>A novel coronavirus virus (2019-nCov) emerged in China in December 2019, which posed an International Public Health Emergency in a couple of weeks, and very recently entered World Health Organization (WHO) status as a very high-risk group. The International Committee on Virus Taxonomy (ICTV...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	Zeshan Haider (Auteur), Maria Javed (Auteur), Numan Yousaf (Auteur)
Formaat:	Boek
Gepubliceerd in:	Global Journal of Clinical Virology - Peertechz Publications, 2021-03-10.
Onderwerpen:	Review Article
Online toegang:	Connect to this object online.
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Impact of SARS-CoV-2 (Coronavirus) Pandemic on Public Mental Health
door: Bilal Javed, et al.
Gepubliceerd in: (2020)

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge
door: Sambit K. Mohanty, et al.
Gepubliceerd in: (2020)

The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status
door: Mbarka Bchetnia, et al.
Gepubliceerd in: (2020)

Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
door: Su Eun Park
Gepubliceerd in: (2020)

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
door: Chao Zhang, et al.
Gepubliceerd in: (2020)

SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses
door: Marcos Felipe Falcão Sobral DSc, et al.
Gepubliceerd in: (2021)

Novel β-Coronavirus (SARS-CoV-2): Current and future aspects of pharmacological treatments
door: Nidhi Tiwari, et al.
Gepubliceerd in: (2020)

Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing.
door: David E Harbourt, et al.
Gepubliceerd in: (2020)

Coronavirus SARS-CoV-2 and Covid-19
door: Armênio Uzunian
Gepubliceerd in: (2020)

Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Colombia
door: Nathalia Zuluaga, et al.
Gepubliceerd in: (2023)

Influence of the coronavirus 2 (SARS-Cov-2) pandemic on acute appendicitis
door: M. Velayos, et al.
Gepubliceerd in: (2020)

Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection
door: Rachel E. Bosserman, et al.
Gepubliceerd in: (2022)

Pulmonary Surfactant: possible intervention against the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
door: Elaine Díaz Casañas, et al.
Gepubliceerd in: (2020)

Breastfeeding and Contraceptive Methods in Women With Severe Acute Respiratory Syndrome Coronavirus- 2 (SARS-COV-2) Infection in Peripartum Period
door: Reena Rani, et al.
Gepubliceerd in: (2022)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
door: Enrique Ambrocio-Ortiz, et al.
Gepubliceerd in: (2021)

Biophysical insights to tackle with the coronavirus SARS-COV-2 by UV
door: Zahra Elyasigorji, et al.
Gepubliceerd in: (2020)

New Coronavirus COVID-19 (SARS-CoV-2)
door: O. V. Shamsheva
Gepubliceerd in: (2020)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest
door: Hayden L. Smith, et al.
Gepubliceerd in: (2021)

Risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seropositivity among nursing home staff
door: Avnika B. Amin, et al.
Gepubliceerd in: (2021)

Novel severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection: Microbiologic perspectives and anatomic considerations for sanctuary sites
door: Onyemaechi O. Azu, et al.
Gepubliceerd in: (2021)

Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2
door: Haiyan Yan, et al.
Gepubliceerd in: (2021)

Secondary attack rates and determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) household transmission in Pakistan: A case-ascertained prospective, longitudinal study
door: Muhammad Imran Nisar, et al.
Gepubliceerd in: (2024)

Effects of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) Delta variant (B.1.617.2) on maternal and neonatal outcomes
door: Kalsang Dolma, et al.
Gepubliceerd in: (2023)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
door: Utkarsh Srivastava, et al.
Gepubliceerd in: (2022)

Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV‐2
door: Simranjeet Singh Sekhon, et al.
Gepubliceerd in: (2023)

Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity
door: Keiji Nakamura, et al.
Gepubliceerd in: (2020)

The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review
door: Leonny Dwi Rizkita, et al.
Gepubliceerd in: (2021)

Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees
door: Andreu Colom-Cadena, et al.
Gepubliceerd in: (2023)

On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: A prospective molecular epidemiology study
door: Patrick Benoit, et al.
Gepubliceerd in: (2023)

Oral clinical courses of patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: A clinical follow up (a prospective prevalent cohort) study
door: Heron Gezahegn Gebretsadik, et al.
Gepubliceerd in: (2021)

Environmental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contamination in hospital rooms during the first and third coronavirus disease 2019 (COVID-19) waves
door: Killian Le Neindre, et al.
Gepubliceerd in: (2022)

Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2)
door: Komal Rizwan, et al.
Gepubliceerd in: (2020)

Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review
door: Paolo Gisondi, et al.
Gepubliceerd in: (2023)

Corrigendum: Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendees
door: Andreu Colom-Cadena, et al.
Gepubliceerd in: (2024)

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific antibodies and T-cell immunity response in pregnant women and neonates
door: Chih Lin, et al.
Gepubliceerd in: (2023)

Coronavirus (COVID-19) pandemic: Outbreak, current scenario and impact on human physiology in Pakistan
door: Komal Jabeen, et al.
Gepubliceerd in: (2021)

Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
door: Jiluo Liu, et al.
Gepubliceerd in: (2021)

Coronavirus (SARS-CoV-2): a systematic review for potential vaccines
door: Mihir Bhatta, et al.
Gepubliceerd in: (2022)

Coronavirus (SARS-CoV-2) and Mortality Rate in India: The Winning Edge
door: Gyaneshwer Chaubey
Gepubliceerd in: (2020)

Correlations of interleukin levels with the severity of SARS-CoV-2 coronavirus infection
door: O. N. Yashkina, et al.
Gepubliceerd in: (2023)